HS 10386
Alternative Names: HS-10386Latest Information Update: 25 Aug 2023
At a glance
- Originator Jiangsu Hansoh Pharmaceutical
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Solid tumours